查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医疗事务的评价(美国)- 溃疡性大肠炎
市场调查报告书
商品编码
1769047

医疗事务的评价(美国)- 溃疡性大肠炎

Medical Affairs Reputations (US) - Ulcerative Colitis
出版日期: | 出版商: FirstWord Group | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

本报告是基于对美国胃肠病学家的调查，对支持溃疡性结肠炎药物的医疗事务团队进行了深入分析。报告探讨了医生与医疗事务团队互动的频率和性质、医生对当前支持的满意度、首选的沟通管道以及影响参与度的关键因素。报告还重点介绍了医疗事务团队的优势和麵临的课题，并就如何优化服务以更好地满足医生需求和提升竞争优势提供了见解。

关键问题解答

  • 1.医师与医疗事务团队的互动频率如何？这种频率是增加还是减少？
  • 2.医师目前如何使用医疗事务团队提供的服务？
  • 3.医疗事务支援的哪些面向对医师最重要？他们对所提供的支援有多满意？
  • 4.医师希望与医学事务团队进行哪种类型的互动？他们希望这种互动的频率是多少？
  • 5.医学事务团队在多大程度上满足了医师的需求？
  • 6.对于某个品牌而言，医学事务团队的表现是低于还是高于预期？
  • 7.未来如何改善医学事务服务，以便更好地满足医师的需求？
  • 8.竞争对手的医学事务团队在哪些方面最薄弱，哪些方面最强？

领导品牌

  • Remicade
  • Humira
  • Simponi
  • entibio
  • Xeljanz
  • Stelara
  • zeposhia
  • rinbokku
  • omubo
  • skyRidge
  • toremufia

研究方法

FirstView 报告是基于对 LiMATM 选定医生进行的定量调查而得出。 LiMATM 是全球最大的医生名录，拥有超过 300 万名经过验证的医生。每位医生均根据严格的筛选标准精心挑选，以确保收集到的见解具有相关性、可靠性，并反映顶尖医疗专业人士的真实想法和经验。调查结果以易于理解的图表形式呈现，方便您快速理解和分析数据。凭藉 LiMATM 的广泛覆盖范围和准确性，FirstView 报告可提供无与伦比的数据驱动洞察，指导您的策略规划，并帮助您在快速发展的医疗保健领域保持领先地位。

我们的报告有何独特之处？

FirstWord Reports 是值得信赖的行业领导者，专注于製药业，为生物製药专业人士和决策者提供深入可行的洞察。我们深厚的行业知识使我们能够为您提供相关且有价值的洞察，帮助您掌握新兴趋势，有效应对复杂课题。我们的报告以广泛的研究以及来自顶尖专家和关键意见领袖 (KOL) 的独立、公正的见解为后盾，为您提供所需的准确性和可靠性。独家访谈和数据，以及持续的市场监测，让您全面了解市场动态。我们的报告涵盖 40 多个活跃的疾病领域，包括 KOL 洞察和定量医生调查在内的医生情报，以及行业专家对医疗事务、数位健康、销售与行销、市场准入和其他领域问题的看法，使您能够做出更明智的数据驱动决策，并在快速变化的行业中保持竞争力。

简介目录

This report provides a detailed analysis of Medical Affairs teams supporting therapies for ulcerative colitis, based on a survey of US gastroenterologists. It explores the frequency and nature of physician interactions with Medical Affairs, physicians' satisfaction with current support, preferred communication channels, and key factors that influence engagement. The report also highlights areas where Medical Affairs teams excel or face challenges, offering insights into how services can be optimized to better meet physician needs and improve competitive positioning.

Key Questions Answered:

  • 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
  • 2. In what ways do physicians currently use the services provided by Medical Affairs teams?
  • 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
  • 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
  • 5. How successful are Medical Affairs teams at meeting physician needs?
  • 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
  • 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
  • 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Key Brands:

  • Remicade
  • Humira
  • Simponi
  • Entyvio
  • Xeljanz
  • Stelara
  • Zeposia
  • Rinvoq
  • Omvoh
  • Skyrizi
  • Tremfya

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.